Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 37% ± 24% | |
| GABAergic neuron | 7 studies | 40% ± 21% | |
| neuron | 5 studies | 25% ± 7% | |
| microglial cell | 5 studies | 21% ± 4% | |
| epithelial cell | 5 studies | 26% ± 10% | |
| endothelial cell | 4 studies | 30% ± 8% | |
| astrocyte | 4 studies | 24% ± 4% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 8% | |
| interneuron | 4 studies | 46% ± 21% | |
| oligodendrocyte | 4 studies | 23% ± 2% | |
| GABAergic interneuron | 3 studies | 23% ± 3% | |
| granule cell | 3 studies | 22% ± 6% | |
| transit amplifying cell | 3 studies | 28% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 8 studies | 35% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2393.62 | 1445 / 1445 | 100% | 19.05 | 183 / 183 |
| prostate | 100% | 2552.45 | 245 / 245 | 100% | 23.74 | 502 / 502 |
| brain | 100% | 7734.06 | 2640 / 2642 | 100% | 26.33 | 705 / 705 |
| breast | 100% | 2379.00 | 459 / 459 | 100% | 27.90 | 1116 / 1118 |
| stomach | 100% | 2281.03 | 359 / 359 | 100% | 17.65 | 285 / 286 |
| intestine | 100% | 2924.09 | 966 / 966 | 100% | 18.13 | 525 / 527 |
| pancreas | 100% | 2740.14 | 328 / 328 | 99% | 15.91 | 177 / 178 |
| bladder | 100% | 2855.29 | 21 / 21 | 99% | 15.18 | 501 / 504 |
| thymus | 100% | 2781.66 | 652 / 653 | 100% | 19.84 | 602 / 605 |
| lung | 99% | 2440.58 | 574 / 578 | 100% | 18.26 | 1155 / 1155 |
| kidney | 100% | 2002.16 | 89 / 89 | 99% | 17.94 | 892 / 901 |
| uterus | 100% | 2265.91 | 170 / 170 | 99% | 16.07 | 454 / 459 |
| adrenal gland | 100% | 2940.12 | 258 / 258 | 99% | 24.80 | 227 / 230 |
| ovary | 100% | 1818.62 | 180 / 180 | 97% | 11.32 | 416 / 430 |
| liver | 99% | 1325.90 | 224 / 226 | 95% | 11.22 | 387 / 406 |
| skin | 100% | 1955.14 | 1803 / 1809 | 94% | 12.30 | 443 / 472 |
| adipose | 100% | 2475.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 13.09 | 29 / 29 |
| muscle | 100% | 3016.35 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1949.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.81 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.74 | 1 / 1 |
| blood vessel | 100% | 2915.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 97% | 2298.01 | 831 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 88% | 8.50 | 70 / 80 |
| peripheral blood | 58% | 996.47 | 539 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0010744 | Biological process | positive regulation of macrophage derived foam cell differentiation |
| GO_0071803 | Biological process | positive regulation of podosome assembly |
| GO_0007254 | Biological process | JNK cascade |
| GO_0097190 | Biological process | apoptotic signaling pathway |
| GO_0090594 | Biological process | inflammatory response to wounding |
| GO_0034614 | Biological process | cellular response to reactive oxygen species |
| GO_0050804 | Biological process | modulation of chemical synaptic transmission |
| GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0071276 | Biological process | cellular response to cadmium ion |
| GO_0038095 | Biological process | Fc-epsilon receptor signaling pathway |
| GO_0042752 | Biological process | regulation of circadian rhythm |
| GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
| GO_0061833 | Biological process | protein localization to tricellular tight junction |
| GO_0090398 | Biological process | cellular senescence |
| GO_0031398 | Biological process | positive regulation of protein ubiquitination |
| GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0048511 | Biological process | rhythmic process |
| GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0004705 | Molecular function | JUN kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MAPK9 |
| Protein name | Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) Stress-activated protein kinase JNK (EC 2.7.11.24) Mitogen-activated protein kinase 9 |
| Synonyms | JNK2 SAPK1A PRKM9 |
| Description | FUNCTION: Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2. In turn, MAPK9/JNK2 phosphorylates a number of transcription factors, primarily components of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional activity. In response to oxidative or ribotoxic stresses, inhibits rRNA synthesis by phosphorylating and inactivating the RNA polymerase 1-specific transcription initiation factor RRN3. Promotes stressed cell apoptosis by phosphorylating key regulatory factors including TP53 and YAP1. In T-cells, MAPK8 and MAPK9 are required for polarized differentiation of T-helper cells into Th1 cells. Upon T-cell receptor (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and MAP3K7/TAK1 to regulate JUN protein levels. Plays an important role in the osmotic stress-induced epithelial tight-junctions disruption. When activated, promotes beta-catenin/CTNNB1 degradation and inhibits the canonical Wnt signaling pathway. Participates also in neurite growth in spiral ganglion neurons. Phosphorylates the CLOCK-BMAL1 heterodimer and plays a role in the regulation of the circadian clock . Phosphorylates POU5F1, which results in the inhibition of POU5F1's transcriptional activity and enhances its proteasomal degradation (By similarity). .; FUNCTION: MAPK9 isoforms display different binding patterns: alpha-1 and alpha-2 preferentially bind to JUN, whereas beta-1 and beta-2 bind to ATF2. However, there is no correlation between binding and phosphorylation, which is achieved at about the same efficiency by all isoforms. JUNB is not a substrate for JNK2 alpha-2, and JUND binds only weakly to it. FUNCTION: Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, and thus regulates transcriptional activity. . FUNCTION: Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, and thus regulates transcriptional activity. . FUNCTION: Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, and thus regulates transcriptional activity. . FUNCTION: Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, and thus regulates transcriptional activity. . FUNCTION: Responds to activation by environmental stress and pro-inflammatory cytokines by phosphorylating a number of transcription factors, and thus regulates transcriptional activity. . |
| Accessions | ENST00000393360.7 [P45984-2] ENST00000425491.6 [P45984-5] D7R526 ENST00000343111.10 [P45984-3] P45984 D7R525 J3KNK1 ENST00000452135.7 [P45984-1] D7R527 ENST00000393362.8 E5RJ57 D7R528 ENST00000523583.1 ENST00000455781.5 [P45984-4] B5BUJ7 ENST00000539014.5 ENST00000347470.8 ENST00000397072.7 |